Toggle navigation
Home
Search
Services
Blog
Contact
About
Screening of Congeners and Evaluate Antitimor Agents
Griswold, Daniel P.
Southern Research Institute, Birmingham, AL, United States
Search 13 grants from Daniel Griswold
Search grants from Southern Research Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Training Program in Mechanisms of Virus-Host Interactions
Risk Assessment for Long-Haul Truck Drivers
GABA Medications and Cocaine Interactions in Humans
HIV/AIDS Prevention and Pacific Islander Adolescents
Mechanism of Replication of Drug Resistance Factors
Recently added grants:
Mechanisms of inv(16) acute myeloid leukemia
Natural killer cell regulation of the germinal center HIV neutralizing antibody response
Engineering Nanomaterials to Prime Immunity
A value affirmation intervention for physical symptoms and medication adherence in breast cancer patients taking aromatase inhibitors
The Impact of Tobacco Control Policies on Health Equity in the United States
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM037552-008
Application #
3610859
Study Section
Project Start
1983-02-16
Project End
1986-02-15
Budget Start
1985-05-17
Budget End
1986-02-15
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205
Related projects
NIH 1985
N01 CM
Screening of Congeners and Evaluate Antitimor Agents
Griswold, Daniel P. / Southern Research Institute
NIH 1985
N01 CM
Screening of Congeners and Evaluate Antitimor Agents
Griswold, Daniel P. / Southern Research Institute
Publications
Dykes, D J; Waud, W R; Harrison Jr, S D et al.
(1989)
Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 33847) against selected tumor systems in mice.
Cancer Res 49:1182-6
Comments
Be the first to comment on Daniel Griswold's grant